Dr. Suresh Juluri is a molecular pharmacologist with over 15 years of Drug Discovery Industrial experience in various Indian Drug Discovery companies like Dr Reddy’s, Advinus and Jubilant. He obtained his PhD degree in Metabolic Disorders from University of Hyderabad. He has over eleven peer-reviewed publications, ten posters at International conferences, three patent applications to his credit. He has worked extensively in the area of Metabolic Disorders on various therapeutic targets. At Dr Reddy’s he played a pivotal role in identifying new chemical entities, which reached to various stages of clinical trials in the area of diabetes. At Advinus he was a project leader for anti- diabetes and anti- obesity target discovery and drug discovery programs. Currently at Jubilant, he leads the Metabolic disorders biology team in various collaborative and exploratory projects for US and Europe based clients namely Lilly, J & J, Merck and Norgine. Actively involved in client interactions and exploring new targets for investigative biology and new target idea generation.
Choosing the Right Cell-Based Assays for Drug Discovery
Monday, 2 March 2015 at 14:30
Add to Calendar ▼2015-03-02 14:30:002015-03-02 15:30:00Europe/LondonChoosing the Right Cell-Based Assays for Drug DiscoveryCellTech India 2015 in Bangalore, IndiaBangalore, IndiaSELECTBIOenquiries@selectbiosciences.com
In this talk, the broad target classes and their
appropriate cell based assays will be covered. It will also highlight the value
of Phenotypic Screening and importance of establishing target engagement in
primary cell types. Further, advantages and caveats of cellular assays will
also be discussed.
Add to Calendar ▼2015-03-02 00:00:002015-03-03 00:00:00Europe/LondonCellTech India 2015CellTech India 2015 in Bangalore, IndiaBangalore, IndiaSELECTBIOenquiries@selectbiosciences.com